News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Key Clinical Data for St. Jude Medical (STJ)'s Structural Heart Technologies Revealed at EuroPCR



5/16/2012 11:16:50 AM

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that significant clinical data for its structural heart portfolio is being presented during EuroPCR. Among the highlights are first-in-man and six-month data for the company’s Portico™ Transcatheter Aortic Heart Valve and results from a multicenter study for AMPLATZER™ Cardiac Plug (ACP) technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES